Autopsy of a multiple lobar hemorrhage case with amyloid-β-related angiitis.


Journal

Neuropathology : official journal of the Japanese Society of Neuropathology
ISSN: 1440-1789
Titre abrégé: Neuropathology
Pays: Australia
ID NLM: 9606526

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 21 10 2019
revised: 18 11 2019
accepted: 18 11 2019
pubmed: 22 1 2020
medline: 2 4 2021
entrez: 22 1 2020
Statut: ppublish

Résumé

A 92-year-old man died of multiple lobar hemorrhage with amyloid-β protein (Aβ)-related angiitis (ABRA) with an unusual pathological appearance. Although he had shown relatively rapid progressive dementia, starting 1 year before death, there was no detailed clinical investigation, and no immunosuppressive or anticoagulant therapy, because of his advanced age. The autopsy showed two lobar hemorrhagic lesions in the right parietal lobe and temporal lobes. Microscopically, almost all the brain's blood vessels showed cerebral amyloid angiopathy with many foci of transmural vasculitis. Infiltrating cells were predominantly CD8-positive T-lymphocytes, but we observed no granulomatous inflammation with appearance of multinucleated giant cells. We found fibrinoid necrosis in some blood vessels and disruption of these blood vessels in the arachnoid space-cerebral cortex junction in the hemorrhagic lesion at the temporal lobe. We also observed an unusual, neutrophil-predominant, abscess-like vasculitis in the subarachnoid space; almost all such unusual vasculitides were located at a short distance from the two lobar hemorrhagic lesions. Serum anti-neutrophil cytoplasmic myeloperoxidase and proteinase-3 antibodies were negative, and the genotype of the apolipoprotein E (ApoE) gene (ApoE) was ε2/ε3. Although we did not observe some of ABRA's typical histopathological findings, transmural and vascular destructive inflammation with Aβ deposition was consistent with ABRA. Vulnerability of blood vessels to fibrinoid necrosis might be associated with disruption of the relevant blood vessels, leading to lobar hemorrhage. ABRA exhibits various clinical and histopathological findings, depending on the patient's age, immune function status, treatment, and ApoE genotype. This is the first case and the oldest (92 years old) autopsy of ABRA associated with ApoE-ε2/ε3 genotype.

Identifiants

pubmed: 31962374
doi: 10.1111/neup.12637
doi:

Substances chimiques

Amyloid beta-Peptides 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

280-286

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP17k09263
Organisme : Japan Society for the Promotion of Science
ID : JP18k10119

Informations de copyright

© 2020 Japanese Society of Neuropathology.

Références

Scolding NJ, Joseph F, Kirby PA et al. Abeta-related angiitis: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005; 128: 500-515.
Danve A, Grafe M, Deodhar A. Amyloid beta-related angiitis-a case report and comprehensive review of literature of 94 cases. Semin Arthritis Rheum 2014; 44: 86-92.
Salvarani C, Morris JM, Giannini C, Brown RD Jr, Christianson T, Hunder GG. Imaging findings of cerebral amyloid angiopathy, abeta-related angiitis (Abra), and cerebral amyloid angiopathy-related inflammation: A single-institution 25-year experience. Medicine 2016; 95: e3613.
Salvarani C, Hunder GG, Morris JM, Brown RD Jr, Christianson T, Giannini C. Aβ-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis. Neurology 2013; 81: 1596-1603.
Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA. Cerebral amyloid angiopathy related inflammation: Three case reports and a review. J Neurol Neurosurg Psychiatry 2011; 82: 20-26.
Nelson PT, Pious NM, Jicha GA et al. Apoe-epsilon2 and apoe-epsilon4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol 2013; 72: 708-715.
Takeda M, Martinez R, Kudo T et al. Apolipoprotein e and central nervous system disorders: Reviews of clinical findings. Psychiatry Clin Neurosci 2010; 64: 592-607.
Nicoll JA, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV. High frequency of apolipoprotein e epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1996; 39: 682-683.
Ogura A, Moriyoshi H, Nakai N et al. A case of amyloid-beta-related cerebral angiitis with apoe epsilon4/epsilon2 genotype. Rinsho Shinkeigaku 2015; 55: 561-566 (in Japanese with English abstract).
Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer's disease-associatedneurofibrillary tangle using paraffin sections and immunohistochemistry. Acta Neuropathol 2006; 112: 389-404.
Giannini C, Salvarani C, Hunder G, Brown RD. Primary central nervous system vasculitis: Pathology and mechanisms. Acta Neuropathol 2012; 123: 59-772.
Moussaddy A, Levy A, Strbian D, Sundararajan S, Berthelet F, Lanthier S. Inflammatory cerebral amyloid angiopathy, amyloid-beta-related angiitis, and primary angiitis of the central nervous system: Similarities and differences. Stroke 2015; 46: e210-e213.
Sakai K, Hayashi S, Sanpei K, Yamada M, Takahashi H. Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy-related inflammation. Neuropathology 2012; 32: 551-556.
Nikolich-Zugich J. The twilight of immunity: Emerging concepts in aging of the immune system. Nat Immunol 2018; 19: 10-19.
Wu J, Li W, Liu Z et al. Ageing-associated changes in cellular immunity based on the senieur protocol. Scand J Immunol 2012; 75: 641-646.

Auteurs

Shojiro Ichimata (S)

Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.

Yukiko Hata (Y)

Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.

Koji Yoshida (K)

Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
Department of Neurology, Hyogo Brain and Heart Center, Himeji, Japan.

Naoki Nishida (N)

Department of Legal Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH